Aggregated Turnover

1. Exclusion of Connected Entities – An Australian software company initially reported only its own income in the R&D Tax Schedule, excluding income from its connected entities in the UK and US. The ATO audit revealed this discrepancy, resulting in the company’s aggregated turnover exceeding AUD 20 million. Consequently, the company had to revise its tax offset claim and include all connected entities’ income, ensuring future compliance.
2. Failure to Report Affiliated Entities – A company involved in renewable energy projects failed to report the income of its affiliated manufacturing entities based in China. The ATO’s review identified this oversight, leading to the disqualification of their R&D tax offset claim. The company then implemented a comprehensive review process to ensure accurate reporting of all affiliated entities’ income in future filings.
3. Excluding International Income – A biotech firm excluded the income of its affiliated research labs in Europe from its aggregated turnover. Upon ATO’s examination, the firm had to correct its R&D tax schedule to include all connected entities’ income. This adjustment ensured compliance and retained their eligibility for the R&D tax offset.
4. Misreporting Turnover of Subsidiaries – A manufacturing company with subsidiaries in Asia reported only the parent company’s income. The ATO discovered this during their audit, resulting in an aggregated turnover that exceeded the AUD 20 million threshold. The company had to amend their tax filings to include all subsidiary income, ensuring correct future reporting.
5. Overlooking Domestic Affiliates – A healthcare company did not include the income of its domestic affiliates in the aggregated turnover. The ATO found this error during the review, which disqualified the company from the refundable tax offset. The healthcare company revised their reporting process to include all affiliated entities’ income accurately.

Payments to Associates

1. Converting Amounts to Loans – A company engaged an associated entity for R&D services, converting the payment into a long-term loan. The ATO found this non-compliant as it did not represent an actual payment. The company had to restructure its payments, ensuring they were made directly and documented properly to meet compliance requirements.
2. Offsetting Against Licensing Fees – A company offset the amount owed to an associate against licensing fees for using intellectual property under development. The ATO disallowed this claim, citing non-compliance. The company re-evaluated its payment structure, making direct payments to the associate to align with the ATO’s guidelines.
3. Round Robin Transactions – A company engaged in round robin transactions, where the associate lent small amounts repeatedly to create the appearance of payment. The ATO scrutinised these transactions, determining them to be artificial and non-compliant. The company corrected its approach by making genuine payments and maintaining proper documentation.
4. Misclassified Payments – A tech firm misclassified payments to an associated entity as R&D expenses. The ATO found these payments were actually for administrative services. The firm had to correct its records, ensuring only genuine R&D payments were claimed.
5. Deferred Payments as Loans – A company deferred payments to an associated entity, recording them as loans. The ATO reviewed this and found it non-compliant. The company restructured its payment process to ensure timely, documented payments to the associated entity.

Conducting R&D Activities

1. Special-Purpose Vehicles – A company set up a special-purpose vehicle to conduct R&D activities, outsourcing the work back to its trading entity. The ATO found that the R&D activities were not conducted for the benefit of the special-purpose vehicle but rather for the trading entity. The company restructured its operations to ensure the R&D activities were conducted for its benefit, bearing the financial risk and controlling the activities.
2. Service Providers – A service provider conducted R&D activities primarily benefiting its clients. The ATO reviewed the claim and found that the primary benefit accrued to the clients, not the service provider. The company revised its contracts to ensure that the R&D activities were conducted for its benefit, maintaining control and ownership of the outcomes.
3. Licensing Agreements – A company entered into a licensing agreement with an associate, allowing the associate to benefit from the R&D activities. The ATO identified this as non-compliant, as the R&D activities were conducted for the associate’s benefit. The company adjusted its agreements to ensure that it retained the primary benefit, financial risk, and control over the R&D activities.
4. Outsourced R&D Work – A company outsourced its R&D work to a related entity but failed to demonstrate that the R&D activities were conducted for its benefit. The ATO found the arrangement non-compliant. The company restructured its agreements to clearly show that the R&D activities were for its benefit and controlled by it.
5. R&D Conducted by Shell Company – A firm used a shell company to conduct its R&D activities. The ATO found that the shell company did not bear the financial risk or control the activities. The firm had to dissolve the shell company and take direct control of the R&D activities to comply with ATO guidelines.

Overseas Expenditure

1. Sub-Contracted Software Development – A company sub-contracted software development work to a multinational firm with developers based overseas. Without obtaining an overseas finding, the ATO disallowed the claim, as the work was conducted outside Australia. The company then obtained the necessary overseas finding and ensured future R&D activities had a significant scientific link to Australian core activities.
2. Overseas Product Manufacturing – A company incurred expenditure to an overseas entity to produce medical equipment. The ATO found this arrangement non-compliant as it lacked an overseas finding. The company subsequently obtained the required finding and demonstrated that the overseas activities were linked to their Australian R&D projects.
3. Freelance Service Providers – A company engaged freelance service providers through an online platform, with individuals conducting activities outside Australia. The ATO disqualified the claim due to the lack of an overseas finding. The company restructured its engagements, obtaining the necessary findings and ensuring the activities were closely linked to their core R&D projects in Australia.
4. Overseas Testing Facilities – A company used overseas testing facilities for its R&D activities without an overseas finding. The ATO rejected the expenditure claim. The company later obtained the required findings and demonstrated the scientific link to its Australian R&D activities.
5. International Research Partnerships – A company partnered with an international research institution, conducting joint R&D activities. The ATO disallowed the claim due to the lack of an overseas finding. The company then obtained the necessary findings and ensured all future activities had the required link to Australian core R&D activities.

Expenditure Not at Risk

1. Government Grants – A company received a government grant for its R&D activities, with payments guaranteed regardless of the R&D outcomes. The ATO determined that the expenditure was not at risk, disqualifying it from the R&D tax incentive. The company restructured its funding agreements, ensuring payments were contingent on achieving specific R&D milestones and bearing the financial risk.
2. Hourly Rate Service Contracts – A company provided R&D services on an hourly rate, receiving payment regardless of the outcomes. The ATO found this arrangement non-compliant, as the expenditure was not genuinely at risk. The company revised its contracts to include outcome-based payments, ensuring the financial risk was properly borne.
3. Contingent Loan Arrangements – A company entered into a loan arrangement with an associated entity, where repayment was contingent on future R&D outcomes. The ATO reviewed the arrangement and found the expenditure was not at risk. The company modified the terms to ensure the loan was genuinely at risk and not guaranteed by future results or offsets.
4. Non-Recourse Loans – A company received non-recourse loans for its R&D activities, where repayment was not required if the R&D failed. The ATO found this non-compliant as the expenditure was not at risk. The company changed its loan agreements to ensure repayment was required regardless of R&D outcomes.
5. Guaranteed Payments for R&D – A company entered into agreements where R&D payments were guaranteed regardless of the success of the R&D activities. The ATO disallowed these claims. The company restructured its agreements to make payments contingent on the achievement of specific R&D milestones, ensuring the expenditures were genuinely at risk.

Hey there! Just a friendly heads-up that these hypothetical examples are here for your reading pleasure and inspiration—they’re not legal or financial advice or reflect actual cases. If you’re reading this and starting to sweat, it might be time to give Bulletpoint a call. We’re here to help straighten things out, especially if you’ve found yourself nodding along a little too hard to some of these stories. Seriously, don’t navigate this maze alone—reach out to us!

So, while these examples are great for illustrating what could go wrong, every case is different. Don’t worry, we’ve got your back. If you want a clearer path to R&D tax success, we’re just a call away.